Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): Evidence for a graft-versus-myeloma effect

Leukemia

Volumn 11, Issue 2, 1997, Pages 281-283

  Bertz, H ^a   Burger, J A ^a   Kunzmann, R ^a   Mertelsmann, R ^a   Finke, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adoptive immunotherapy; Allogeneic BMT; Graft versus multiple myeloma effect; Multiple myeloma

Indexed keywords

ALPHA INTERFERON; CD3 ANTIGEN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CASE REPORT; CELL TRANSPLANTATION; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; LIVER DISEASE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031058106     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400546     Document Type: Article

References (7)

1. Kolb HJ, Mittermuller J, Clemm CH, Holler E, Ledderose G, Brehm G, Heim M, Willmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
2. Kolb HJ, Schattenberg A, Goldman JM et al. Craft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 1995; 86: 2041-2050.
3. Hertenstein B, Stefanic M, Sandherr M, Bunjes D, Mertens T, Arnold R. Treatment of steroid-resistant acute graft-versus-host disease after allogeneic marrow transplantation with anti interleukin-2 receptor antibody (BT563). Transplant Proc 1994; 26: 3114-3116.
4. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, Small TN, Young JW, O'Reilly RJ. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.
5. Verdonck LF, Lokhorst HM, Dekker AW, Nieuwenhuis HK, Petersen EJ. Graft-versus-myeloma effect in two cases. Lancet 1996; 347; 800-801.
6. Tricot G, Vesole D, Jagannath S, Munshi N, Barlogie B. Graft-versus myeloma effect: proof of principle. Blood 1996; 87: 1996-1198.
7. Kwak LW, Taub DD, Duffey PL, Bensinger WI, Bryant EM, Reynolds CW, Longo DL. Transfer of myeloma idiotype-specific immunity from an actively immunized marrow donor. Lancet 1995; 345: 1016-1020.